Lumason FDA Approval History
Last updated by Judith Stewart, BPharm on Dec 5, 2019.
FDA Approved: Yes (First approved October 10, 2014)
Brand name: Lumason
Generic name: sulfur hexafluoride lipid microsphere
Dosage form: Injectable Suspension
Company: Bracco Diagnostics Inc.
Treatment for: Diagnosis and Investigation
Lumason (sulfur hexafluoride lipid microsphere) is a contrast agent used for ultrasound imaging.
Development timeline for Lumason
| Date | Article |
|---|---|
| Oct 10, 2014 | Approval FDA Approves Lumason Ultrasound Imaging Agent |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
